Alum, an aluminum-based adjuvant, induces Sjögren's syndrome-like disorder in mice

Clinical and Experimental Rheumatology

Volumn 32, Issue 2, 2014, Pages 251-255

  Bagavant, Harini ^a,b   Nandula, Seshagiri Rao ^a,c   Kaplonek, Paulina ^b   Rybakowska, Paulina D ^a,b   Deshmukh, Umesh S ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adjuvants; Sialoadenitis; Sj gren's syndrome

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTINUCLEAR ANTIBODY; LA ANTIBODY; RO ANTIBODY; ADJUVANT; AUTOANTIBODY; LA ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; BLOOD LEVEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INCIDENCE; INNATE IMMUNITY; PROTEIN DETERMINATION; PROTEIN FUNCTION; SALIVA ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM; ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED STRAINS; MONITORING, PHYSIOLOGIC; MUSCARINIC AGONISTS; PILOCARPINE; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84904725061     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. TINCANI A, ANDREOLI L, CAVAZZANA I et al.: Novel aspects of Sjögren's syndrome in 2012. BMC Med 2013; 11: 93.
2. LOW HZ, WITTE T: Aspects of innate immunity in Sjögren's syndrome. Arthritis Res Ther 2011; 13: 218.
3. DESHMUKH US, OHYAMA Y, BAGAVANT H, GUO X, GASKIN F, FU SM: Inflammatory stimuli accelerate Sjögren's syndrome-like disease in (NZB x NZW) F1 mice. Arthritis Rheum 2008; 58: 1318-23.
4. NANDULA SR, SCINDIA YM, DEY P, BAGAVANT H, DESHMUKH US: Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease. Oral Dis 2011; 17: 801-7.
5. SZCZERBA BM, RYBAKOWSKA PD, DEY P et al.: Type I interferon receptor deficiency prevents murine Sjogren's syndrome. J Dent Res 2013; 92: 444-9.
6. EISENBARTH SC, COLEGIO OR, O'CONNOR W, SUTTERWALA FS, FLAVELL RA: Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453: 1122-6.
7. LI H, WILLINGHAM SB, TING JP, RE F: Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 2008; 181: 17-21.
8. RUDOFSKY UH, EVANS BD, BALABAN SL, MOTTIRONI VD, GABRIELSEN AE: Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 1993; 68: 419-26.
9. GUO X, BAGAVANT H, BROWN MG, FU SM, DESHMUKH US: Role of innate and adaptive immune responses in differential susceptibility to IFA induced Sjögren's syndrome-like disease in NZM mouse strains. Arthritis Rheum 2006; 54: s313-s313.
10. WILLEKE P, SCHOTTE H, SCHLüTER B et al.: Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome. Ann Rheum Dis 2003; 62: 359-62.
11. BOMBARDIERI M, BARONE F, PITTONI V et al.: Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 2004; 6: R447-56.
12. BALDINI C, ROSSI C, FERRO F et al.: The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome. J Intern Med 2013; 274: 480-9.
13. LESTER S, STOKES L, SKARRATT K et al.: Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome. Arthritis Res Ther 2013; 15: R71.
14. CRUZ-TAPIAS P, AGMON-LEVIN N, ISRAELI E, ANAYA JM, SHOENFELD Y: Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA)-animal models as a proof of concept. Curr Med Chem 2013; 20: 4030-6.
15. FAVOINO E, FAVIA EI, DIGIGLIO L, RACANELLI V, SHOENFELD Y, PEROSA F: Effects of adjuvants for human use in systemic lupus erythematosus (Sle)-prone (Nzb/Nzw) F1 mice. Clin Exp Immunol. 2014; 175: 32-40.